Precision BioSciences
DTIL
51 hedge funds and large institutions have $29.8M invested in Precision BioSciences in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 3 closing their positions.
333% more capital inflows, than outflows
Capital inflows: $2.03M | Capital outflows: $468K
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
9% more funds holding
Funds holding: 47 → 51 (+4)
0.35% more ownership
Funds ownership: 45.62% → 45.97% (+0.35%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$664K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$379K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$320K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$259K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$184K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Moloney Securities Asset Management
Manchester,
Missouri
|
-$168K |
| 2 |
Redwood Wealth Management Group
Medford,
New Jersey
|
-$150K |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
-$88.4K |
| 4 |
Tower Research Capital (TRC)
New York
|
-$31.1K |
| 5 |
Renaissance Technologies
New York
|
-$23.1K |
DTIL Hedge Fund Activity: Q3 2024 in Review
51 of the 6,986 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q3 2024, worth a combined $29.8M — down 3.1% from $30.8M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new DTIL positions and 3 closed out — a net gain of 4 holders — while 11 added to existing stakes and 9 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $664K. The largest seller was Moloney Securities Asset Management, cutting an estimated $168K.
- 51 institutional investors held Precision BioSciences (DTIL) as of Q3 2024, up from 47 in Q2 2024.
- Funds reported $29.8M of Precision BioSciences stock for Q3 2024, down 3.1% quarter-over-quarter.
- 7 funds opened new Precision BioSciences positions in Q3 2024 and 3 closed out, a net change of +4 holders.
- The largest Precision BioSciences buyer in Q3 2024 was Janus Henderson Group, an estimated $664K added.
- The largest Precision BioSciences seller in Q3 2024 was Moloney Securities Asset Management, an estimated $168K sold.
Based on aggregated 13F filings for Q3 2024.